Ditchcarbon
  • Contact
  1. Organizations
  2. Genus
Public Profile
Pharmaceutical Preparation Manufacturing
GB
updated a month ago

Genus

Company website

Genus plc, commonly referred to as Genus, is a leading global biotechnology company headquartered in Great Britain. Founded in 1939, Genus has established itself as a pioneer in the animal genetics industry, focusing on improving livestock productivity and health through innovative breeding solutions. With major operations across Europe, North America, and Asia, Genus offers a diverse range of products and services, including advanced genetic technologies and breeding programmes for cattle, pigs, and poultry. Their unique approach combines cutting-edge science with a commitment to sustainability, positioning them as a market leader in animal breeding and genetics. Notable achievements include significant advancements in genomic selection and a strong emphasis on animal welfare, which have solidified Genus's reputation as a trusted partner in the agricultural sector.

DitchCarbon Score

How does Genus's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

29

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

32

Industry Benchmark

Genus's score of 29 is higher than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.

52%

Let us know if this data was useful to you

Genus's reported carbon emissions

In 2023, Genus reported total carbon emissions of approximately 6,748,040 kg CO2e, comprising 309,140 kg CO2e from Scope 1 and 6,438,900 kg CO2e from Scope 2 emissions. This marks an increase from 2022, when emissions totalled about 5,802,500 kg CO2e, with Scope 1 emissions at 257,740 kg CO2e and Scope 2 emissions at 5,544,760 kg CO2e. Genus has not disclosed any Scope 3 emissions data, and there are currently no specific reduction targets or climate pledges outlined in their reports. The company does not appear to inherit emissions data from a parent organization, as indicated by the absence of cascaded data. Overall, while Genus has made strides in tracking its emissions, further commitments and reduction initiatives would enhance its climate strategy.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20222023
Scope 1
257,740
000,000
Scope 2
5,544,760
0,000,000
Scope 3
-
-

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Genus's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Genus is in GB, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Genus is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Boehringer Ingelheim Animal Health do Brasil Ltda.

BR
•
Pharmaceutical Preparation Manufacturing
Updated 24 days ago

Cegelec SAS

FR
•
Electrical machinery and apparatus n.e.c. (31)
Updated 20 days ago

Dechra

GB
•
Pharmaceutical Preparation Manufacturing
Updated 15 days ago

Neogen

GB
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Virbac group

FR
•
Pharmaceutical Preparation Manufacturing
Updated 27 days ago

Boehringer Ingelheim Pharmaceuticals, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 16 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251008.2
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy